Bis(3)-tacrine inhibits the sustained potassium current in cultured rat hippocampal neurons

Physiol Res. 2017 Jul 18;66(3):539-544. doi: 10.33549/physiolres.933354. Epub 2017 Feb 28.

Abstract

Bis(3)-tacrine is a dimeric AChE inhibitor derived from tacrine with a potential to treat Alzheimer's disease. It was recently been reported to act as a fast off-rate antagonist of NMDA receptors with moderate affinity. In the present study, we aimed to explore whether bis(3)-tacrine could modulate the function of native sustained potassium current in cultured rat hippocampal neurons using whole-cell patch-clamp technique. We found that bis(3)-tacrine inhibited the amplitude of sustained potassium current in a reversible and concentration-dependent manner, with a potency two orders of magnitude higher than that of tacrine. The inhibition was voltage-independent between 0 to +60 mV. The IC(50) values for bis(3)-tacrine and tacrine inhibition of sustained potassium current were 0.45+/-0.07 and 50.5+/-4.8 microM, respectively. I-V curves showed a more potent inhibition of sustained potassium current by bis(3)-tacrine (1 microM) compared to tacrine at the same concentration. Bis(3)-tacrine hyperpolarized the activation curve of the current by 11.2 mV, albeit leaving the steady-state inactivation of the current unaffected.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cholinesterase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Electric Stimulation / methods
  • Hippocampus / drug effects
  • Hippocampus / physiology*
  • Kv1.2 Potassium Channel / antagonists & inhibitors*
  • Kv1.2 Potassium Channel / physiology*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Neurons / drug effects
  • Neurons / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Tacrine / pharmacology*

Substances

  • Cholinesterase Inhibitors
  • Kv1.2 Potassium Channel
  • Tacrine